Clinical trials
Observational Macular Degeneration trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 3 |
| 2011 | 1 |
| 2015 | 5 |
| 2017 | 1 |
| 2019 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 9 |
| Completed | 6 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
| Terminated | 1 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medical University of Vienna | 7 |
| The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | 4 |
| Rudolf Foundation Clinic | 2 |
| University of Southampton | 2 |
| Vienna Institute for Research in Ocular Surgery | 2 |
| Augenabteilung Allgemeines Krankenhaus Linz | 1 |
| Hospital Hietzing | 1 |
| Johannes Kepler University of Linz | 1 |
| Medical University of Graz | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Macular Degeneration | 24 |
| Choroidal Neovascularization | 2 |
| Retinal Vein Occlusion | 2 |
| Cataract | 1 |
| Diabetic Retinopathy | 1 |
| Geographic Atrophy | 1 |
| Refractive Errors | 1 |
| Retinal Diseases | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.